US EditionGlenmark to launch generic version of Adderall Tablets in the US market by May 2025 - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Glenmark to launch generic version of Adderall Tablets in the US market by May 2025 - Express Pharma
Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the upcoming launch of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulphate and Amphetamine Sulphate Tablets—also referred to as Mixed Salts of a Single Entity Amphetamine Product—in strengths of 5 mg, 10 mg, 15 mg, 20 mg and 30 mg. Glenmark confirmed that its product is bioequivalent and therapeutically equivalent to the reference listed drug, Adderall Tablet…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
